1
|
Martínez-Laperche C, Sanz-Villanueva L, Díaz Crespo FJ, Muñiz P, Martín Rojas R, Carbonell D, Chicano M, Suárez-González J, Menárguez J, Kwon M, Diez Martín JL, Buño I, Bastos Oreiro M. Correction: EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment. BMC Cancer 2022; 22:1224. [PMID: 36443715 PMCID: PMC9703722 DOI: 10.1186/s12885-022-10335-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022] Open
Affiliation(s)
- C. Martínez-Laperche
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Department of Hematology, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), C/ Doctor Esuerdo 46, 28007 Madrid, Spain
| | - L. Sanz-Villanueva
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Department of Hematology, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), C/ Doctor Esuerdo 46, 28007 Madrid, Spain
| | - F. J. Díaz Crespo
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Pathology Department, Gregorio Maranon General University Hospital, Madrid, Spain
| | - P. Muñiz
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Department of Hematology, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), C/ Doctor Esuerdo 46, 28007 Madrid, Spain
| | - R. Martín Rojas
- grid.410526.40000 0001 0277 7938Department of Hematology, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), C/ Doctor Esuerdo 46, 28007 Madrid, Spain
| | - D. Carbonell
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Department of Hematology, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), C/ Doctor Esuerdo 46, 28007 Madrid, Spain
| | - M. Chicano
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Department of Hematology, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), C/ Doctor Esuerdo 46, 28007 Madrid, Spain
| | - J. Suárez-González
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Genomics Unit, Gregorio Maranon General University Hospital, IiSGM, Madrid, Spain
| | - J. Menárguez
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Pathology Department, Gregorio Maranon General University Hospital, Madrid, Spain
| | - M. Kwon
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Department of Hematology, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), C/ Doctor Esuerdo 46, 28007 Madrid, Spain
| | - J. L. Diez Martín
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Department of Hematology, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), C/ Doctor Esuerdo 46, 28007 Madrid, Spain ,grid.4795.f0000 0001 2157 7667Department of Medicine, School of Medicine, Complutense University of Madrid, Madrid, Spain
| | - I. Buño
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Department of Hematology, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), C/ Doctor Esuerdo 46, 28007 Madrid, Spain ,grid.410526.40000 0001 0277 7938Genomics Unit, Gregorio Maranon General University Hospital, IiSGM, Madrid, Spain ,grid.4795.f0000 0001 2157 7667Department of Cellular Biology, School of Medicine, Complutense University of Madrid, Madrid, Spain
| | - M. Bastos Oreiro
- grid.410526.40000 0001 0277 7938Gregorio Maranon Health Research Institute (IiSGM), Madrid, Spain ,grid.410526.40000 0001 0277 7938Department of Hematology, Gregorio Marañón General University Hospital, Gregorio Marañón Health Research Institute (IiSGM), C/ Doctor Esuerdo 46, 28007 Madrid, Spain
| |
Collapse
|
2
|
Martínez-Laperche C, Sanz-Villanueva L, Díaz Crespo FJ, Muñiz P, Martín Rojas R, Carbonell D, Chicano M, Suárez-González J, Menárguez J, Kwon M, Diez Martín JL, Buño I, Bastos Oreiro M. EZH2 mutations at diagnosis in follicular lymphoma: a promising biomarker to guide frontline treatment. BMC Cancer 2022; 22:982. [PMID: 36104682 PMCID: PMC9476261 DOI: 10.1186/s12885-022-10070-z] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/27/2022] [Accepted: 08/05/2022] [Indexed: 11/10/2022] Open
Abstract
AbstractEZH2 is mutated in nearly 25% of follicular lymphoma (FL) cases. Little is known about how EZH2 affects patients’ response to therapy. In this context, the aim of this study was to retrospectively analyze the frequency of mutations in EZH2 at diagnosis in tissue and ctDNA in patients with FL and to assess the patients’ outcomes after receiving immunochemotherapy, depending on the EZH2 mutation status. Among the 154 patients included in the study, 27% had mutated EZH2 (46% with high-grade and 26% with low-grade FL). Of the mutated tissue samples, the mutation in ctDNA was identified in 44% of cases. EZH2 mutation in ctDNA was not identified in any patient unmutated in the tissue.Unmutated patients who received R-CHOP had significantly more relapses than patients who received R-Bendamustine (16/49 vs. 2/23, p = 0.040). Furthermore, our results show that patients with mutated EZH2 treated with R-CHOP vs. those treated with R-Bendamustine present a lower incidence of relapse (10% vs. 42% p = 0.09 at 4 years), a higher PFS (92% vs. 40% p = 0.039 at 4 years), and higher OS (100% vs. 78% p = 0.039 at 4 years). Based on these data, RCHOP could be a more suitable regimen for mutated patients, and R-bendamustine for unmutated patients. These findings could mean the first-time identification of a useful biomarker to guide upfront therapy in FL.
Collapse
|
3
|
Sanz‐Villanueva L, Díaz Crespo F, Martín Rojas R, Carbonell D, Chicano M, Suárez‐González J, Muñiz P, Menárguez J, Kwon M, Diez Martín JL, Buño I, Martínez‐Laperche C, Bastos Oreiro M. ANALYSIS OF
EZH2
MUTATIONS IN SOLID AND LIQUID BIOPSY AND ITS ROLE AS PREDICTIVE BIOMARKER FOR CHEMOTHERAPY IN PATIENTS WITH FOLLICULAR LYMPHOMA. Hematol Oncol 2021. [DOI: 10.1002/hon.38_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- L. Sanz‐Villanueva
- Gregorio Marañón Health Research Institute (IiSGM) Gregorio Marañón General University Hospital Department of Hematology Madrid Spain
| | - F. Díaz Crespo
- Gregorio Marañón Gregorio Marañón General University Hospital Pathology Department Madrid Spain
| | - R. Martín Rojas
- Gregorio Marañón General University Hospital Department of Hematology Madrid Spain
| | - D. Carbonell
- Gregorio Marañón Health Research Institute (IiSGM) Gregorio Marañón General University Hospital Department of Hematology Madrid Spain
| | - M. Chicano
- Gregorio Marañón Health Research Institute (IiSGM) Gregorio Marañón General University Hospital Department of Hematology Madrid Spain
| | - J. Suárez‐González
- Gregorio Marañón Health Research Institute (IiSGM) Gregorio Marañón General University Hospital Genomics Unit Madrid Spain
| | - P. Muñiz
- Gregorio Marañón Health Research Institute (IiSGM) Gregorio Marañón General University Hospital Department of Hematology Madrid Spain
| | - J. Menárguez
- Gregorio Marañón General University Hospital Department of Hematology and Pathology Madrid Spain
| | - M. Kwon
- Gregorio Marañón Health Research Institute (IiSGM) Gregorio Marañón General University Hospital Department of Hematology Madrid Spain
| | - J. L. Diez Martín
- Gregorio Marañón Health Research Institute (IiSGM) Gregorio Marañón General University Hospital Department of Hematology Complutense University of Madrid, Department of Medicine Madrid Spain
| | - I. Buño
- Gregorio Marañón Health Research Institute (IiSGM) Gregorio Marañón General University Hospital Department of Hematology and Genomics Unit Complutense University of Madrid Department of Cellular Biology Madrid Spain
| | - C. Martínez‐Laperche
- Gregorio Marañón Health Research Institute (IiSGM) Gregorio Marañón General University Hospital Department of Hematology Madrid Spain
| | - M. Bastos Oreiro
- Gregorio Marañón Health Research Institute (IiSGM) Gregorio Marañón General University Hospital Department of Hematology Madrid Spain
| |
Collapse
|
4
|
Bastos‐Oreiro M, Bailén R, Silva P, Monsalvo S, Pérez Corral A, Carbonell D, Díaz Crespo F, Gómez‐Fernández I, Oarbeascoa G, Dorado N, Muñoz C, Sabell S, Menarguez J, Martínez‐Laperche C, Buño I, Anguita Velasco J, Díez‐Martín JL, Kwon M. RELAPSE CHARACTERIZATION IN DIFFUSE LARGE B CELL LYMPHOMA PATIENTS UNDERGOING COMMERCIAL CAR‐T CELL THERAPY: EXPERIENCE FROM A SINGLE CENTRE. Hematol Oncol 2021. [DOI: 10.1002/hon.180_2880] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
Affiliation(s)
- M. Bastos‐Oreiro
- Hospital Universitario Gregorio Marañón, *equal contribution Hematology Madrid Spain
| | - R. Bailén
- Hospital Universitario Gregorio Marañón, *equal contribution Hematology Madrid Spain
| | - P. Silva
- Hospital Universitario Gregorio Marañón Hematology Madrid Spain
| | - S. Monsalvo
- Hospital Universitario Gregorio Marañón Hematology Madrid Spain
| | - A. Pérez Corral
- Hospital Universitario Gregorio Marañón Hematology Madrid Spain
| | - D. Carbonell
- Hospital Universitario Gregorio Marañón Hematology Madrid Spain
| | - F. Díaz Crespo
- Hospital Universitario Gregorio Marañón Pathology Madrid Spain
| | | | - G. Oarbeascoa
- Hospital Universitario Gregorio Marañón Hematology Madrid Spain
| | - N. Dorado
- Hospital Universitario Gregorio Marañón Hematology Madrid Spain
| | - C. Muñoz
- Hospital Universitario Gregorio Marañón Hematology Madrid Spain
| | - S. Sabell
- Hospital Universitario Gregorio Marañón Hematology Madrid Spain
| | - J. Menarguez
- Hospital Universitario Gregorio Marañón Pathology Madrid Spain
| | | | - I. Buño
- Hospital Universitario Gregorio Marañón Hematology Madrid Spain
| | | | | | - M. Kwon
- Hospital Universitario Gregorio Marañón Hematology Madrid Spain
| |
Collapse
|
5
|
Jerez A, Merino M, Buño I, Chen-Liang TH, Iniesta P, Garcia A, Teruel R, Amigo M, Alamo J, Suarez J, Ortuño F, Vicente V. Donor Cell MDS with Rare Complex Karyotype After Mismatch Alobmt for Ph+ALL. Leuk Res 2017. [DOI: 10.1016/s0145-2126(17)30409-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
6
|
Martínez-Moreno M, Leiva M, Aguilera-Montilla N, Sevilla-Movilla S, Isern de Val S, Arellano-Sánchez N, Gutiérrez NC, Maldonado R, Martínez-López J, Buño I, García-Marco JA, Sánchez-Mateos P, Hidalgo A, García-Pardo A, Teixidó J. In vivo adhesion of malignant B cells to bone marrow microvasculature is regulated by α4β1 cytoplasmic-binding proteins. Leukemia 2015; 30:861-72. [PMID: 26658839 DOI: 10.1038/leu.2015.332] [Citation(s) in RCA: 25] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/11/2015] [Revised: 10/23/2015] [Accepted: 11/24/2015] [Indexed: 12/14/2022]
Abstract
Multiple myeloma (MM) and chronic lymphocytic leukemia (CLL) cells must attach to the bone marrow (BM) microvasculature before lodging in the BM microenvironment. Using intravital microscopy (IVM) of the BM calvariae we demonstrate that the α4β1 integrin is required for MM and CLL cell firm arrest onto the BM microvasculature, while endothelial P-selectin and E-selectin mediate cell rolling. Talin, kindlin-3 and ICAP-1 are β1-integrin-binding partners that regulate β1-mediated cell adhesion. We show that talin and kindlin-3 cooperatively stimulate high affinity and strength of α4β1-dependent MM and CLL cell attachment, whereas ICAP-1 negatively regulates this adhesion. A functional connection between talin/kindlin-3 and Rac1 was found to be required for MM cell attachment mediated by α4β1. Importantly, IVM analyses with talin- and kindlin-3-silenced MM cells indicate that these proteins are needed for cell arrest on the BM microvasculature. Instead, MM cell arrest is repressed by ICAP-1. Moreover, MM cells silenced for talin and kindlin-3, and cultured on α4β1 ligands showed higher susceptibility to bortezomib-mediated cell apoptosis. Our results highlight the requirement of α4β1 and selectins for the in vivo attachment of MM and CLL cells to the BM microvasculature, and indicate that talin, kindlin-3 and ICAP-1 differentially control physiological adhesion by regulating α4β1 activity.
Collapse
Affiliation(s)
- M Martínez-Moreno
- Department of Cellular and Molecular Medicine, Centro de Investigaciones Biológicas (CSIC), Madrid, Spain
| | - M Leiva
- Area of Cell and Developmental Biology, Fundación Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain
| | - N Aguilera-Montilla
- Department of Cellular and Molecular Medicine, Centro de Investigaciones Biológicas (CSIC), Madrid, Spain
| | - S Sevilla-Movilla
- Department of Cellular and Molecular Medicine, Centro de Investigaciones Biológicas (CSIC), Madrid, Spain
| | - S Isern de Val
- Department of Cellular and Molecular Medicine, Centro de Investigaciones Biológicas (CSIC), Madrid, Spain
| | - N Arellano-Sánchez
- Department of Cellular and Molecular Medicine, Centro de Investigaciones Biológicas (CSIC), Madrid, Spain
| | - N C Gutiérrez
- Department of Hematology, Hospital Universitario de Salamanca, Salamanca, Spain
| | - R Maldonado
- Section of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - J Martínez-López
- Section of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain
| | - I Buño
- Section of Hematology, Hospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio Marañón, Madrid, Spain
| | - J A García-Marco
- Hematology Unit, Hospital Universitario Puerta de Hierro, Madrid, Spain
| | - P Sánchez-Mateos
- Section of Immuno-Oncology, Hospital General Universitario Gregorio Marañón, Complutense University School of Medicine, Madrid, Spain
| | - A Hidalgo
- Area of Cell and Developmental Biology, Fundación Centro Nacional de Investigaciones Cardiovasculares, Madrid, Spain.,Institute for Cardiovascular Prevention, Ludwig-Maximilians-University, Munich, Germany
| | - A García-Pardo
- Department of Cellular and Molecular Medicine, Centro de Investigaciones Biológicas (CSIC), Madrid, Spain
| | - J Teixidó
- Department of Cellular and Molecular Medicine, Centro de Investigaciones Biológicas (CSIC), Madrid, Spain
| |
Collapse
|
7
|
Perez-Chacon G, Martinez-Laperche C, Rebolleda N, Somovilla-Crespo B, Muñoz-Calleja C, Buño I, Zapata J. 39 Phytochemical indole-3-carbinol synergizes strongly with fludarabine and induces p53-dependent and -independent cell death in chronic lymphocytic leukemia cells irrespective of their IGHV mutation state and treatment resistances. Eur J Cancer 2014. [DOI: 10.1016/s0959-8049(14)70165-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
8
|
Kwon M, Martínez-Laperche C, Balsalobre P, Serrano D, Anguita J, Gayoso J, Díez-Martín JL, Buño I. Early peripheral blood and T-cell chimerism dynamics after umbilical cord blood transplantation supported with haploidentical cells. Bone Marrow Transplant 2013; 49:212-8. [PMID: 24212562 DOI: 10.1038/bmt.2013.177] [Citation(s) in RCA: 15] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/10/2013] [Revised: 09/19/2013] [Accepted: 09/23/2013] [Indexed: 11/09/2022]
Abstract
Single-unit umbilical cord blood (CB) SCT is limited by low total nucleated cell (TNC) dose. Co-infusion of CD34+ cells from a third party HLA-mismatched donor, known as dual or haplo-cord transplant, reduces the period of post-transplant neutropenia and related complications. The aim of this study was to analyze the value of early post-transplant peripheral blood (PB) and T cell chimerism after 28 dual transplants regarding CB engraftment. Cumulative incidence of myeloid engraftment at 30 days was 93% with a median time to engraftment of 14 days (10-29). Patients who developed CB graft failure (n=5) showed very low percentages of CB cells on days +14, +21 and +28 with decreasing dynamics. On the other hand, percentages of CB cells in patients who achieved CB engraftment increased over time. Interestingly, such patients showed two distinct chimerism dynamics in PB, but all of them showed a predominance of CB T cells early after SCT with increasing dynamics over time. Early post-transplant chimerism dynamics in PB and T cells predicts CB graft failure enabling rapid therapeutic measures to be applied. On the other hand, early increasing percentages of CB T cells correlates with ultimate CB engraftment.
Collapse
Affiliation(s)
- M Kwon
- Gregorio Marañón Institute for Health Research, Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - C Martínez-Laperche
- Gregorio Marañón Institute for Health Research, Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - P Balsalobre
- Gregorio Marañón Institute for Health Research, Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - D Serrano
- Gregorio Marañón Institute for Health Research, Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - J Anguita
- Gregorio Marañón Institute for Health Research, Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - J Gayoso
- Gregorio Marañón Institute for Health Research, Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - J L Díez-Martín
- Gregorio Marañón Institute for Health Research, Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| | - I Buño
- Gregorio Marañón Institute for Health Research, Department of Hematology, Hospital General Universitario Gregorio Marañón, Madrid, Spain
| |
Collapse
|
9
|
Martín-Antonio B, Suarez-Lledo M, Arroyes M, Fernández-Avilés F, Martínez C, Rovira M, Espigado I, Gallardo D, Bosch A, Buño I, Martínez-Laperche C, Jiménez-Velasco A, de la Cámara R, Brunet S, Nieto JB, Urbano-Ispizua Á. A variant in IRF3 impacts on the clinical outcome of AML patients submitted to Allo-SCT. Bone Marrow Transplant 2013; 48:1205-11. [DOI: 10.1038/bmt.2013.43] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/26/2012] [Revised: 01/25/2013] [Accepted: 02/21/2013] [Indexed: 12/16/2022]
|
10
|
Gayoso J, Balsalobre P, Serrano D, Kwon M, Buño I, Rodriguez G, Anguita J, Pérez Corral A, Díez-Martín J. Iv Busulfan Based Conditioning Regimen for Haploidentical Transplantation. Biol Blood Marrow Transplant 2012. [DOI: 10.1016/j.bbmt.2011.12.396] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/14/2022]
|
11
|
Radice C, Muñoz V, Castellares C, Casanova M, Serrano D, Carrión R, Balsalobre P, Buño I, Díez-Martín JL. Listeria monocytogenes meningitis in two allogeneic hematopoietic stem cell transplant recipients. Leuk Lymphoma 2006; 47:1701-3. [PMID: 16966293 DOI: 10.1080/10428190600648135] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022]
MESH Headings
- Adult
- Anemia, Refractory, with Excess of Blasts/complications
- Anemia, Refractory, with Excess of Blasts/therapy
- Drug Resistance, Bacterial
- Hematopoietic Stem Cell Transplantation/adverse effects
- Humans
- Lymphoma, Non-Hodgkin/complications
- Lymphoma, Non-Hodgkin/therapy
- Male
- Meningitis, Listeria/diagnosis
- Meningitis, Listeria/etiology
- Middle Aged
- Transplantation, Homologous
Collapse
|
12
|
Buño I, Kwon M, Balsalobre P, Serrano D, Carrión R, Gómez-Pineda A, Díez-Martín JL. Heterogeneous loss of the Y chromosome in leukocyte lineages of donor origin after stem cell transplantation. Bone Marrow Transplant 2006; 38:463-5. [PMID: 16892070 DOI: 10.1038/sj.bmt.1705470] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
|
13
|
Balsalobre P, Buño I, Serrano D, Carrion R, Carrasco S, Gomez-Pineda A, Diez-Martin J. Clinical usefulness of the electronic management of the stem cell transplant schedule: Clinical evolution of candidate patients. Biol Blood Marrow Transplant 2006. [DOI: 10.1016/j.bbmt.2005.12.021] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
14
|
Buño I, Nava P, Alvarez-Doval A, Alvarez-Rodríguez F, Díez-Martín JL, Menárguez J. Lymphoma associated chromosomal abnormalities can easily be detected by FISH on tissue imprints. An underused diagnostic alternative. J Clin Pathol 2005; 58:629-33. [PMID: 15917416 PMCID: PMC1770679 DOI: 10.1136/jcp.2004.021733] [Citation(s) in RCA: 14] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/26/2022]
Abstract
BACKGROUND Fluorescence in situ hybridisation (FISH) is useful for detecting specific chromosomal abnormalities in various tumours. In lymphomas, diagnosis is frequently made using paraffin wax embedded tissue. However, FISH performed under these conditions presents potential technical problems and difficulties in interpretation. AIMS To show that FISH using tissue imprints and cytopreps or alternatively, bone marrow (BM) smears, constitutes an easy and rapid strategy to overcome these constraints. METHODS The study comprised 46 patients with lymphoma. Sixty nine tissue imprints, cytopreps, or BM smears were analysed by FISH. Dual colour, dual fusion FISH probes were used to detect the t(8;14), t(11;14), and t(14;18) translocations, whereas a dual colour breakapart FISH probe was used to detect chromosomal translocations involving the BCL6 gene. RESULTS Tissue imprints and cytopreps were successfully hybridised in all 52 cases, whereas hybridisation was successful in 16 of 17 archival BM smears. All patients could be analysed to identify either the presence or absence of chromosomal translocations. CONCLUSIONS The use of tissue imprints, cytopreps, or BM smears to identify chromosomal abnormalities by FISH is a rapid and useful ancillary approach for diagnostic purposes. Therefore, it could be used on a routine basis whenever fresh samples are available.
Collapse
MESH Headings
- Bone Marrow/pathology
- Chromosomes, Human, Pair 11/genetics
- Chromosomes, Human, Pair 14/genetics
- Chromosomes, Human, Pair 18/genetics
- Chromosomes, Human, Pair 8/genetics
- DNA-Binding Proteins/genetics
- Humans
- In Situ Hybridization, Fluorescence/methods
- Lymphoma, B-Cell/genetics
- Proto-Oncogene Proteins/genetics
- Proto-Oncogene Proteins c-bcl-6
- Sensitivity and Specificity
- Specimen Handling/methods
- Transcription Factors/genetics
- Translocation, Genetic
Collapse
Affiliation(s)
- I Buño
- Bone Marrow Transplant Unit, Hospital G.U. Gregorio Marañón, C/ Doctor Esquerdo 46, 28007 Madrid, Spain
| | | | | | | | | | | |
Collapse
|
15
|
Jiménez-Velasco A, Barrios M, Román-Gómez J, Navarro G, Buño I, Castillejo JA, Rodríguez AI, García-Gemar G, Torres A, Heiniger AI. Reliable quantification of hematopoietic chimerism after allogeneic transplantation for acute leukemia using amplification by real-time PCR of null alleles and insertion/deletion polymorphisms. Leukemia 2005; 19:336-43. [PMID: 15674363 DOI: 10.1038/sj.leu.2403622] [Citation(s) in RCA: 57] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
Increasing mixed chimerism (MC) after allogeneic stem cell transplantation (SCT) has been associated with a high risk of relapse in acute leukemia. We evaluated a new method for chimerism detection, based on the quantitative real-time PCR (qrt-PCR) amplification of null alleles or insertion/deletion polymorphisms (indels). All qrt-PCR assays with null alleles and indels attained a sensitivity of at least 10(-4), as well as good intra- and interassay concordance, and a high accuracy in experiments with cell mixtures. Informativeness was found in 80.3% of the 61 donor/recipient pairs tested. Nonrelapsed patients showed a progressive decrease in peripheral blood chimerism to values below 0.01% (complete chimerism (CC)). Bone marrow chimerism failed to reach CC more than 4 years after SCT. Increasing MC was observed prior to relapse in 88.2% of patients. Compared with conventional PCR amplification of variable number of tandem repeats, qrt-PCR predicted a significantly higher number of relapses (88.2 vs 44.4%) with a median anticipation period of 58 days. In conclusion, chimerism determination by qrt-PCR amplification of null alleles and indels constitutes a useful tool for the follow-up of patients with acute leukemia after SCT, showing better results than those obtained with conventional PCR.
Collapse
|
16
|
Díez-Martín JL, Gómez-Pineda A, Serrano D, Carrión R, Balsalobre P, Buño I. Successful treatment of incipient graft rejection with donor leukocyte infusions, further proof of a graft versus host lymphohaemopoietic effect. Bone Marrow Transplant 2004; 33:1037-41. [PMID: 15064692 DOI: 10.1038/sj.bmt.1704488] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Graft rejection is a major cause of treatment failure after T-cell-depleted stem cell transplantation (TCD-SCT) and remains a therapeutic challenge. Donor leukocyte infusions (DLIs) have an efficient graft versus host effect, which has been successfully used to treat recipient relapses. We hypothesized that this effect could be exploited to counteract the host versus graft reactions responsible for graft rejection. We report two adult patients with haematological malignancies who underwent sex-mismatched TCD-SCT from HLA-identical sibling donors. Peripheral blood (PB) counts and bone marrow (BM) cellularity were studied on a serial basis. Sequential chimaerism and minimal residual disease analysis were performed by FISH on PB and BM samples as well as on leukocyte lineages (T and B lymphocytes and myeloid cells) purified from PB using immunomagnetic technology. Both patients were diagnosed with incipient graft rejection 2-3 months after engraftment, based on persistently decreasing PB counts and BM cellularity together with the observation of decreasing mixed chimaerism (increasing percentage of recipient cells), mostly in whole PB and T lymphocytes. Both patients were successfully treated with a single DLI (1 x 10(7) CD3+ cells/kg), thereafter achieving normal PB counts and BM cellularity as well as complete chimaerism. Interestingly, the only side effect observed was mild graft versus host disease that did not require treatment. In conclusion, provided that an early diagnosis is made, the graft versus host lymphohaemopoietic effect harboured by immunocompetent donor cells can be successfully used for the treatment of incipient graft rejection.
Collapse
Affiliation(s)
- J L Díez-Martín
- Unidad de Trasplante de Médula Osea, Hosp. G.U. Gregorio Marañón, Doctor Esquerdo 46, 28007 Madrid, Spain.
| | | | | | | | | | | |
Collapse
|
17
|
Buño I, Anta B, Moreno-López E, Balsalobre P, Balas A, García-Sánchez F, Serrano D, Carrión R, Gómez-Pineda A, Díez-Martín JL. Lineage-specific chimaerism quantification after T-cell depleted peripheral blood stem cell transplantation. Leuk Lymphoma 2003; 44:659-67. [PMID: 12769344 DOI: 10.1080/1042819031000067738] [Citation(s) in RCA: 10] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/27/2022]
Abstract
Patients that receive a T-cell depleted (TCD) hematopoietic stem cell transplantation (SCT) show higher risk of graft failure/rejection and of disease relapse than those that receive unmanipulated grafts. The purpose of the present investigation was to analyze the usefulness of chimaerism quantification in bone marrow (BM), peripheral blood (PB), and leukocyte lineages such as T lymphocytes (CD3+,both CD4+ and CD8+), B lymphocytes (CD19+) and myeloid cells (CD15+), for the early detection of graft failure/rejection episodes and disease relapse after TCD-PBSCT. Two of the ten (2/10) patients included in the study showed stable complete chimaerism (CC). The other 8/10 patients showed decreasing mixed chimaerism (MC) and 7 of them had either graft failure (n = 1)/rejection (n = 3) or disease relapse (n = 3). In two patients relapsed from chronic myeloid leukemia, MC was observed in BM and PB, with higher percentages of autologous cells in BM, as well as in leukocyte lineages, with higher percentages of recipient cells in the myeloid lineage than in lymphocytes. Combined analysis of chimaerism and minimal residual disease allowed early diagnosis of relapse and successful rescue therapy with donor leukocyte infusions (DLI), before the onset of hematological relapse. Chimaerism analysis allowed early diagnosis of incipient graft rejection in 3 patients. These patients showed MC both in BM and PB, with greater percentages of recipient cells in PB. Analysis of leukocyte lineages showed higher percentages of autologous cells in T lymphocytes (mainly CD8+) than in B or myeloid cells. Two of these patients were successfully treated with DLI and recovered normal PB counts and BM cellularity, as well as CC. The graft versus recipient hemopoiesis effect harbored by the donor immunocompetent cells infused seems useful forthe treatment of graft rejection, provided that an early diagnosis is made.
Collapse
Affiliation(s)
- I Buño
- Unidad de Trasplante de Médula Osea, Hosp. G.U. Gregorio Marañón, Madrid, Spain.
| | | | | | | | | | | | | | | | | | | |
Collapse
|
18
|
Maas F, Schaap N, Kolen S, Zoetbrood A, Buño I, Dolstra H, de Witte T, Schattenberg A, van de Wiel-van Kemenade E. Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms. Leukemia 2003; 17:630-3. [PMID: 12646954 DOI: 10.1038/sj.leu.2402857] [Citation(s) in RCA: 18] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Affiliation(s)
- F Maas
- Central Hematology Laboratory, University Medical Center St Radboud, Nijmegen, The Netherlands
| | | | | | | | | | | | | | | | | |
Collapse
|
19
|
Maas F, Schaap N, Kolen S, Zoetbrood A, Buño I, Dolstra H, de Witte T, Schattenberg A, van de Wiel-van Kemenade E. Quantification of donor and recipient hemopoietic cells by real-time PCR of single nucleotide polymorphisms. Leukemia 2003; 17:621-9. [PMID: 12646953 DOI: 10.1038/sj.leu.2402856] [Citation(s) in RCA: 66] [Impact Index Per Article: 3.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/09/2022]
Abstract
Analysis of changes in recipient and donor hemopoietic cell origin is extremely useful to monitor the effect of stem cell transplantation (SCT) and sequential adoptive immunotherapy by donor lymphocyte infusions (DLI). We developed a sensitive and accurate method to quantify the percentage of recipient and donor cells by real-time PCR using single nucleotide polymorphisms (SNPs) as markers. Allele-specific PCR of seven SNPs resulted in specific markers for donor or recipient in 97% of HLA-identical sibling pairs. Both, recipient- and donor-derived hemopoietic cells can be simultaneously analyzed in 67% sibling pairs. We expect this can be increased to approximately 99% by developing three additional SNP-PCR. Serial dilution of SNP-positive DNA into either SNP-negative DNA or water revealed a detection limit of 0.1-0.01% depending on the amount of input DNA and start C(t) of the used SNP-PCR. Application of our real-time SNP-PCR method for a CML patient treated by allogeneic SCT and DLI demonstrated its feasibility to follow donor T-cell chimerism and early detection of residual and recurrent autologous hemopoiesis in response to treatment. This detailed monitoring of the genetic origin of hemopoietic cells, in particular immune effector cells and target cells after SCT and DLI, may substantially contribute to understanding of the mechanisms that play a role in the success of treatment.
Collapse
Affiliation(s)
- F Maas
- Central Hematology Laboratory, University Medical Center St Radboud, Nijmegen, The Netherlands
| | | | | | | | | | | | | | | | | |
Collapse
|
20
|
Díez-Martín JL, Buño I, Llamas P, Gosálvez J, López-Fernández C, Polo N, Regidor C. Fluorescence in situ hybridization evaluation of minimal residual disease on stem-cell harvests. Cancer Detect Prev 2001; 24:169-72. [PMID: 10917138] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/17/2023]
Abstract
The usefulness of fluorescence in situ hybridization (FISH) analysis to detect minimal residual disease (MRD) in autologous bone marrow and peripheral blood stem-cell harvests has been tested in three patients with hematologic malignancies. Conventional cytogenetics and FISH were used to characterize the leukemic clones identifying the specific chromosomal abnormalities (monosomy 7 in a myelodysplastic patient and trisomy 8 in two acute myeloid leukemic patients). Such analysis was useful to monitor the MRD persistent after treating these patients with intensive chemotherapy. The myelodysplastic patient underwent eight peripheral blood-stem cell harvests in which FISH detected the persistence of monosomy 7 cells, precluding their use for autologous transplantation. This patient relapsed and died. In two acute myeloid leukemia patients who underwent an autologous marrow harvest, FISH did not show a significant proportion of trisomy 8 cells. Nevertheless, autologous transplantation was not performed, owing to an insufficient CD34 cell content in the harvests. One of these patients relapsed with the reappearance of trisomy 8 and died. The other patient, on the contrary, is alive in complete remission 3 years after the bone marrow harvest. The usefulness and applicability of MRD quantification in stem-cell harvests is discussed on the basis of the sensitivity of the methodology applied.
Collapse
MESH Headings
- Adolescent
- Adult
- Chromosome Aberrations
- Female
- Hematopoietic Stem Cell Transplantation
- Humans
- In Situ Hybridization, Fluorescence
- Leukemia, Myeloid/diagnosis
- Leukemia, Myeloid/genetics
- Leukemia, Myeloid/therapy
- Leukemia, Myeloid, Acute/diagnosis
- Leukemia, Myeloid, Acute/genetics
- Leukemia, Myeloid, Acute/therapy
- Male
- Middle Aged
- Myelodysplastic Syndromes/diagnosis
- Myelodysplastic Syndromes/genetics
- Myelodysplastic Syndromes/therapy
- Neoplasm, Residual/diagnosis
- Tissue and Organ Harvesting
- Transplantation, Autologous
Collapse
|
21
|
Buño I, Fernández JL, López-Fernández C, Díez-Martín JL, Gosálvez J. Sau3A in situ digestion of human chromosome 3 pericentrometric heterochromatin. I. Differential digestion of alpha-satellite and satellite 1 DNA sequences. Genome 2001; 44:120-7. [PMID: 11269345 DOI: 10.1139/gen-44-1-120] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
In situ digestion with the restriction endonuclease (RE) Sau3A (Sau3A REISD) uncovers a polymorphism for the pericentromeric heterochromatin of human chromosome 3, which can be positively stained (3+) or not (3-), and has proven useful to differentiate donor and recipient cells after sex-matched bone marrow transplantation and to analyze the so-called hemopoietic chimerism. The aim of the present investigation was to obtain insight into the molecular basis of such polymorphism to optimize its use for chimerism quantification using methodological approaches other than REISD. To this end, fluorescence in situ hybridization (FISH) assays using probes for the satellite DNA sequences that mainly constitute chromosome 3 pericentromeric heterochromatin (alpha-satellite and satellite 1 DNA) were performed on control and Sau3A-digested chromosomes. The results obtained suggest that chromosome 3 alpha-satellite DNA is digested in all individuals studied, irrespective of the karyotype obtained by Sau3A REISD (3++, 3+-, 3--), and thus it does not seem to be involved in the polymorphism uncovered by Sau3A on this chromosome. Satellite 1 DNA is not digested in any case, and shows a polymorphism for its domain size, which correlates with the polymorphism uncovered by Sau3A in such a way that 3+ chromosomes show a large domain (3L) and 3- chromosomes show a small domain (3S). It seems, therefore, that the cause of the polymorphism uncovered by Sau3A on the pericentromeric region of chromosome 3 is a difference in the size of the satellite 1 DNA domain. Small satellite 1 DNA domains fall under the resolution level of REISD technique and are identified as 3-.
Collapse
Affiliation(s)
- I Buño
- Unidad de Trasplante de Médula Osea, Hospital GU Gregorio Marañon, Madrid, Spain.
| | | | | | | | | |
Collapse
|
22
|
Buño I, Fernández JL, López-Fernández C, Díez-Martín JL, Gosálvez J. Sau3A in situ digestion of human chromosome 3 pericentromeric heterochromatin. I. Differential digestion of α-satellite and satellite 1 DNA sequences. Genome 2001. [DOI: 10.1139/g00-088] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/22/2022]
Abstract
In situ digestion with the restriction endonuclease (RE) Sau3A (Sau3A REISD) uncovers a polymorphism for the pericentromeric heterochromatin of human chromosome 3, which can be positively stained (3+) or not (3), and has proven useful to differentiate donor and recipient cells after sex-matched bone marrow transplantation and to analyze the so-called hemopoietic chimerism. The aim of the present investigation was to obtain insight into the molecular basis of such polymorphism to optimize its use for chimerism quantification using methodological approaches other than REISD. To this end, fluorescence in situ hybridization (FISH) assays using probes for the satellite DNA sequences that mainly constitute chromosome 3 pericentromeric heterochromatin (α-satellite and satellite 1 DNA) were performed on control and Sau3A-digested chromosomes. The results obtained suggest that chromosome 3 α-satellite DNA is digested in all individuals studied, irrespective of the karyotype obtained by Sau3A REISD (3++, 3+, 3--), and thus it does not seem to be involved in the polymorphism uncovered by Sau3A on this chromosome. Satellite 1 DNA is not digested in any case, and shows a polymorphism for its domain size, which correlates with the polymorphism uncovered by Sau3A in such a way that 3+ chromosomes show a large domain (3L) and 3 chromosomes show a small domain (3S). It seems, therefore, that the cause of the polymorphism uncovered by Sau3A on the pericentromeric region of chromosome 3 is a difference in the size of the satellite 1 DNA domain. Small satellite 1 DNA domains fall under the resolution level of REISD technique and are identified as 3.Key words: heterochromatin, α-satellite DNA, classical satellite DNA, satellite 1 DNA, restriction endonucleases, FISH.
Collapse
|
23
|
Remstein ED, Kurtin PJ, Buño I, Bailey RJ, Proffitt J, Wyatt WA, Hanson CA, Dewald GW. Diagnostic utility of fluorescence in situ hybridization in mantle-cell lymphoma. Br J Haematol 2000; 110:856-62. [PMID: 11054068 DOI: 10.1046/j.1365-2141.2000.02303.x] [Citation(s) in RCA: 98] [Impact Index Per Article: 4.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/20/2022]
Abstract
Mantle-cell lymphoma (MCL) has a poorer prognosis than other small B-cell lymphomas, thus a definitive diagnosis is essential. The t(11;14)(q13;q32) associated with MCL juxtaposes portions of CCND1 (11q13) and IGH (14q32), resulting in over-expression of cyclin D1. In this study, a highly sensitive two-colour fluorescence in situ hybridization (FISH) method was developed to detect t(11;14)(q13;q32) in nuclei isolated from paraffin-embedded tissue. Twenty-three MCLs, 13 normal controls and nine small B-cell lymphomas other than MCL were studied by FISH. Each MCL had been previously investigated to detect genomic IGH-CCND1 fusion by polymerase chain reaction (PCR) using DNA extracted from frozen tissue. The IGH-CCND1 fusion detection rate in the MCLs was 96% by FISH compared with 35% by PCR. By FISH, one MCL and three small B-cell lymphomas other than MCL harboured abnormalities involving only IGH. Less than 1% of cells showed false-positive IGH-CCND1 fusion in normal specimens by FISH. Thus, this highly sensitive FISH assay is very useful in confirming the diagnosis of MCL, has wide applicability as it may be performed on both paraffin-embedded and fresh tissue, and may also facilitate detection of translocations involving these loci in tumours other than MCL.
Collapse
MESH Headings
- Case-Control Studies
- Chromosomes, Human, Pair 11
- Chromosomes, Human, Pair 14
- Humans
- Immunophenotyping
- In Situ Hybridization, Fluorescence
- Interphase
- Leukemia, Lymphocytic, Chronic, B-Cell/diagnosis
- Lymph Nodes
- Lymphoma, Mantle-Cell/diagnosis
- Palatine Tonsil
- Pilot Projects
- Polymerase Chain Reaction
- Sensitivity and Specificity
- Translocation, Genetic
Collapse
Affiliation(s)
- E D Remstein
- Division of Hematopathology, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
| | | | | | | | | | | | | | | |
Collapse
|
24
|
Buño I, de la Torre J, Torroja E, Fernández JL, López-Fernández C, Díez-Martín JL, Gosálvez J. Chimerism quantification after sex-matched BMT: how probable is it to find donor/recipient pairs with distinguishable cells? Cancer Genet Cytogenet 1999; 113:152-5. [PMID: 10484982 DOI: 10.1016/s0165-4608(99)00002-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 11/19/2022]
Abstract
Chimerism quantification (CQ) after sex-matched bone marrow transplantation (BMT) is based on the identification of autosomal differences distinguishable at the chromosomal level, such as variations within constitutive heterochromatin between the recipient and the donor. The probability of finding distinguishable recipient/donor pairs at the karyotypic level depends on the frequency of the chromosome variants or morphs in the population, on whether recipient and donor are related, and if so, their kinship relation. We have developed a population genetics-based method that allows the estimation of the percentage of post-BMT CQ expected to be informative using any autosomal polymorphic marker. This method has been developed for the most common transplant situations, such as sibling-matched recipient/donor pairs, haploidentical related (parental/filial) pairs, and unrelated pairs. The method developed was applied to a polymorphism of the pericentromeric region of chromosome 3. This polymorphism becomes evident after in situ digestion with the restriction endonuclease Sau3A, and can be successfully used for CQ. It has been estimated that approximately 59% of the cases of BMT from unrelated donors, 36% of those from sibling donors, and 42% from parental/filial donors, are expected to be distinguishable for post-BMT CQ using this approach.
Collapse
Affiliation(s)
- I Buño
- Dpto. de Biología, Universidad Autónoma de Madrid, Spain
| | | | | | | | | | | | | |
Collapse
|
25
|
Buño I, Díez-Martín JL, López-Fernández C, Fernández JL, Gosálvez J. Polymorphisms for the size of heterochromatic regions allow sex-independent quantification of post-BMT chimerism targeting metaphase and interphase cells. Haematologica 1999; 84:138-41. [PMID: 10091412] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/11/2023] Open
Abstract
BACKGROUND AND OBJECTIVE Fully quantitative cytological techniques for the analysis of hemopoietic chimerism are very limited and largely restricted to sex-chromosome detection after sex-mismatched bone marrow transplants (BMTs). The aim of the present investigation was to assess the usefulness of autosomal polymorphisms for the size of heterochromatic regions in the identification of donor and recipient cells and therefore in the quantification of the hemopoietic chimerism after sex-matched BMT. DESIGN AND METHODS Hemopoietic chimerism was followed up in 3 transplanted patients targeting a polymorphism for the size of the pericentromeric heterochromatin (PCH) of chromosome 9, uncovered by restriction endonuclease (RE) in situ digestion (REISD) with the RE Sau3A, to differentiate donor and recipient cells on conventional bone marrow chromosome preparations. RESULTS The polymorphism for the size of the PCH of chromosome 9 allowed differentiation of donor and recipient cells targeting both metaphase and interphase nuclei. The misidentification error for the polymorphism for the size of HPC of chromosome 9 was estimated as 1% for metaphases and 6-11% for interphases. The 3 cases studied showed complete chimerism in the first post-BMT sample analyzed, which was maintained in 2 of them. One patient relapsed and showed transient mixed chimerism. One month later, this patient achieved a second complete remission, showing complete chimerism again. In this patient, who received a sex-mismatched BMT, chimerism was also quantified by sex-chromosome identification using established methods, such as conventional cytogenetics and FISH, and the results obtained were similar to those rendered by Sau3A-REISD. INTERPRETATION AND CONCLUSIONS The polymorphism for the size of the PCH of chromosome 9 uncovered by Sau3A-REISD allows accurate quantification of the hemopoietic chimerism after sex-matched BMT.
Collapse
Affiliation(s)
- I Buño
- Dpto. de Biología, Universidad Autónoma de Madrid, Spain.
| | | | | | | | | |
Collapse
|
26
|
Abstract
Cytoskeleton elements play an important role in cellular processes including normal and pathological conditions or even cell death. Although immunofluorescence microscopy techniques have proved useful to study the cytoskeleton, description and comparative results commonly rely on the direct visual analysis of the targeted cells. We report here an objective and quantitative method to analyze the cytoskeletal pattern of cultured HeLa cells based on image processing and analysis (IPA) of fluorescent labelled cytoskeleton components. Different structural quantifiable characteristics using IPA facilities (densitometric profile, number of branched points, Euler number, convexity, orientation value) allow accurate characterization and differentiation of the three types of fibre nets studied (microtubules, actin microfilament, and cytokeratin intermediate filaments). The application of the analytical methods presented here provides information concerning the organization and modification of cytoskeleton components, and could aid in the further understanding of structural and functional aspects of the cytoskeleton under normal and pathological conditions.
Collapse
Affiliation(s)
- I Buño
- Department of Biology, Faculty of Sciences, Autonomous University of Madrid, Spain
| | | | | | | | | | | |
Collapse
|
27
|
Buño I, Wyatt WA, Zinsmeister AR, Dietz-Band J, Silver RT, Dewald GW. A special fluorescent in situ hybridization technique to study peripheral blood and assess the effectiveness of interferon therapy in chronic myeloid leukemia. Blood 1998; 92:2315-21. [PMID: 9746769] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023] Open
Abstract
Using a highly sensitive fluorescence in situ hybridization method with probes for BCR and ABL1 (D-FISH), we studied 37 paired sets of bone marrow and blood specimens, collected within 24 to 96 hours of each other, from 10 patients before and during treatment for chronic myeloid leukemia (CML). The normal range for 500 interphase nuclei was </=4 (</=0.8%) nuclei based on 10 bone marrow and 10 blood specimens from normal individuals. The percentage of neoplastic nuclei was usually lower in blood than bone marrow. However, changes in the percentage of neoplastic nuclei in blood and bone marrow tracked closely over the course of therapy and with the results of quantitative cytogenetic studies on bone marrow. This result indicates that D-FISH is useful to test blood from patients with CML to monitor therapy. Moreover, by analysis of 6,000 nuclei with D-FISH, residual disease was identified in bone marrow and blood for patients in complete cytogenetic remission. Consequently, D-FISH analyses of interphase nuclei from blood could substitute for Q-cytogenetic studies on bone marrow. Thus, it may not be necessary to collect bone marrow samples so frequently to monitor therapy in CML.
Collapse
MESH Headings
- Antimetabolites, Antineoplastic/therapeutic use
- Biomarkers, Tumor/analysis
- Biomarkers, Tumor/genetics
- Blood Cells/chemistry
- Blood Cells/ultrastructure
- Bone Marrow/chemistry
- Bone Marrow/ultrastructure
- Cell Nucleus/chemistry
- Cell Nucleus/ultrastructure
- Combined Modality Therapy
- Cytarabine/therapeutic use
- DNA, Neoplasm/analysis
- DNA, Neoplasm/genetics
- Fusion Proteins, bcr-abl/analysis
- Fusion Proteins, bcr-abl/genetics
- Genes, abl
- Humans
- Immunologic Factors/therapeutic use
- In Situ Hybridization, Fluorescence/methods
- Interferon alpha-2
- Interferon-alpha/therapeutic use
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive/blood
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive/drug therapy
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive/genetics
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive/pathology
- Leukemia, Myelogenous, Chronic, BCR-ABL Positive/therapy
- Organ Specificity
- Recombinant Proteins
- Remission Induction
- Treatment Outcome
Collapse
Affiliation(s)
- I Buño
- Division of Laboratory Genetics and Section of Biostatistics, Mayo Clinic and Mayo Foundation, Rochester, MN 55905, USA
| | | | | | | | | | | |
Collapse
|
28
|
Díez-Martín JL, Llamas P, Gosálvez J, López-Fernández C, Polo N, de la Fuente MS, Buño I. Conventional cytogenetics and FISH evaluation of chimerism after sex-mismatched bone marrow transplantation (BMT) and donor leukocyte infusion (DLI). Haematologica 1998; 83:408-15. [PMID: 9658724] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/08/2023] Open
Abstract
BACKGROUND AND OBJECTIVES Sensitive and quantitative cytogenetic methods to better assess the biological significance of post-BMT chimerism have been recently developed. In this study, we compared the results of chimerism analysis and evolution employing conventional cytogenetics and fluorescence in situ hybridization (FISH) in 16 patients after sex-mismatched BMT, and in 5 patients after donor lymphocyte infusion (DLI) to treat post-BMT relapse. DESIGN AND METHODS FISH studies were performed using separate digoxigenin labeled centromeric DNA probes for the X (pDMX1) and Y (DYZ1/DYZ3) chromosomes. To this purpose, different types of samples were used: bone marrow (BM) and peripheral blood (PB) slides processed for conventional cytogenetics, and routine BM and PB smears. RESULTS Results of chimerism studies performed on different types of samples showed no significant differences. No significant differences in the ability to identify the sex of each cell with both pDMX1 and DYZ1/DYZ3 probes were found and the results obtained from independent experiments showed a high linear correlation. Chimerism analysis by FISH showed initial mixed chimerism after BMT in 10 patients. Seven of these patients were also studied by conventional cytogenetics and 2 of these showed mixed chimerism. Seven of the former 10 patients evolved to complete donor chimera. 6 patients showed cytogenetic or hematologic bone marrow relapse, 3 of which were preceded by mixed chimaerism as revealed by FISH studies. FISH studies permitted an easy and accurate monitorization of the response to DLI in 5 relapsed patients, showing an increase in the proportion of donor cells in 4 patients as they reached a new complete remission. INTERPRETATION AND CONCLUSIONS Both FISH and conventional cytogenetics are quantitative methods to assess chimerism. However, FISH is more sensitive, accurate and can even be applied on routine BM and PB smears. Furthermore, its combination with immunophenotyping approaches to quantify chimerism on cell subpopulations, will help to clarify post-BMT chimerism significance.
Collapse
Affiliation(s)
- J L Díez-Martín
- Department of Hematology, Clínica Puerta de Hierro, Madrid, Spain.
| | | | | | | | | | | | | |
Collapse
|
29
|
Gosálvez J, Buño I, López-Fernández C, Fernández JL, Goyanes VJ. Image analysis of murine chromatin fiber structure after in situ digestion with restriction endonucleases. Anal Quant Cytol Histol 1997; 19:207-14. [PMID: 9196803] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
OBJECTIVE To determine and quantify the differences produced in chromatin structure after selective in situ DNA digestion with restriction endonuclease (RE). STUDY DESIGN Chromatin fiber structure from a murine cell line was analyzed under light and electron microscopy before and after in situ digestion with AluI, HinfI and HaeIII using digital image analysis (DIA). The proposed DIA-based method entails the generation of a binary image and a skeleton characteristic of the chromatin fiber. Morphologic features (surface, perimeter, shape, number of triple points and Euler number) of the chromatin structure can then be quantified from the digitized images. The results of these experiments were compared with those obtained from direct digestion of naked DNA using the same endonucleases in an attempt to correlate the distribution of restriction sites, according to the DNA fragment size obtained, with the extent of chromatin disorganization after RE in situ digestion. RESULTS Homologous chromatin fiber regions are differentially affected by the action of each RE, although they are indistinguishable under light microscopy. CONCLUSION The proposed analytical routine constitutes a valuable tool for uncovering subtle alterations in the structure of chromatin fiber that has been modified under different experimental conditions.
Collapse
Affiliation(s)
- J Gosálvez
- Department of Biology, Faculty of Science, Autonomous University of Madrid, Spain
| | | | | | | | | |
Collapse
|
30
|
Buño I, López-Fernández C, Díez-Martín JL, Gosálvez J. Dynamics of Sau3A in situ digestion of human chromosomes analyzed with computerized imaging. Genome 1997; 40:123-6. [PMID: 9061918 DOI: 10.1139/g97-017] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/03/2023]
Abstract
The differential DNA removal obtained after in situ digestion of human metaphase chromosomes with the restriction endonuclease Sau3A was analyzed on complete and partially digested nuclei using computerized imaging. The results obtained permit the discrimination of Sau3A-resistant chromosome regions (pericentromeric constitutive heterochromatin on chromosomes 3 and 9) from those partially digested (Yq12 and pericentromeric heterochromatin on other chromosomes), according to the digestion dynamics deduced from the grey intensity profile along each chromosome. This approach permits an accurate labelling of chromosome markers for the identification of genomes from different individuals. This is of special interest for the analysis of the chimeric status found in patients after allogenic bone marrow transplantation.
Collapse
Affiliation(s)
- I Buño
- Departamento de Biología, Facultad de Ciencias, Universidad Autónoma de Madrid, Spain
| | | | | | | |
Collapse
|
31
|
Fernández JL, Valverde D, Goyanes V, Buño I, Gosálvez J. AluI in situ digestion of human alphoid and classical satellite DNA regions: high-resolution digital image analysis of FISH signals from condensed and extended chromatin. Cytogenet Cell Genet 1997; 76:94-100. [PMID: 9154135 DOI: 10.1159/000134522] [Citation(s) in RCA: 9] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/04/2023]
Abstract
Human lymphocyte chromatin either extended or condensed in interphase nuclei and chromosomes was in situ digested by the restriction endonuclease AluI and then hybridized with alphoid probes specific for chromosome 1 (D1Z5 locus), for chromosome X (DXZ1 locus), and with a classical satellite DNA probe specific for chromosome 9 (D9Z1 locus). Fluorescent hybridization signals were quantified by digital analysis of high-resolution images obtained by a Photo-CD system in an attempt to analyze the differential DNA removal produced by AluI in specific repetitive DNA sequences with known restriction site frequency and distribution. The analysis of area and average pixel grey count of hybridization signals suggests that the greater the degree of chromatin stretching, the higher the accessibility of the probe and/or reporter molecules to the target. Nevertheless, this greater hybridization efficiency does not result in a higher fluorescence intensity due to dispersion of individual signals. Specific repetitive DNA at D9Z1 locus (classical) remained impervious to digestion, while that at DXZ1 (alphoid) was extensively removed, according to the frequency and distribution of restriction sites. Nevertheless, though the restriction sites were at least as frequent as at the DXZ1 locus, DNA at the D1Z5 locus (alphoid) was only partially removed. This indicates that chromatin organization within the C-band partially prevents extraction of alphoid sequences, supporting the hypothesis that alphoid DNA sequences are differentially organized among chromosomes. Overall, the same results were obtained from condensed and extended chromatin, suggesting that higher-order chromatin organization does not influence the in situ DNA cleavage and removal by AluI.
Collapse
Affiliation(s)
- J L Fernández
- Laboratorio de Genética Molecular y Radiobiología, Centro Oncológico de Galicia, La Coruña, Spain
| | | | | | | | | |
Collapse
|
32
|
Díez-Martín JL, Buño I, López-Fernández C, Fernández MN, Polo N, Gosálvez J. Restriction endonuclease in situ digestion (REISD): a novel quantitative sex-independent method to analyze chimerism after bone marrow transplantation. Exp Hematol 1996; 24:1333-9. [PMID: 8862445] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/02/2023]
Abstract
Restriction endonuclease (RE) in situ digestion (REISD) of human metaphase chromosomes and interphase nuclei may uncover cryptic polymorphisms. This technique can be applied to identify the individual origin of cells and thus analyze the hemopoietic chimerism that eventually results in leukemic patients after allogeneic bone marrow transplantation (BMT). In the current study, results of REISD with different REs are shown. In particular, the use of Sau 3A reveals a polymorphism for constitutive heterochromatin of chromosome 3 and may differentiate BMT donor (D) and recipient (R) cells. Once pre-BMT characterization shows a different Sau 3A digestion pattern of D and R cells, it is possible to monitor the development of hematopoietic cell populations in the R bone marrow after BMT. A panel of 24 patients who underwent BMT and their Ds were analyzed. The method presented here allowed cells from D and R to be distinguished, and therefore to quantify the post-BMT hemopoletic chimerism, in 6 (25%) of the cases. This quantitative and sex-independent genetic approach to the study of hemopoietic chimerism has already shown itself to be useful in patients with leukemia who require a BMT, but could also be extended to other transplant situations.
Collapse
Affiliation(s)
- J L Díez-Martín
- Servicio de Hematología, Clínica Puerta de Hierro, Madrid, Spain
| | | | | | | | | | | |
Collapse
|
33
|
Gosálvez J, López-Fernández C, Buño I, Polo N, Llamas P, Fernández MN, Fernández JL, Díez-Martín JL. Restriction endonuclease in situ digestion (REISD) and fluorescence in situ hybridization (FISH) as complementary methods to analyze chimerism and residual disease after bone marrow transplantation. Cancer Genet Cytogenet 1996; 89:141-5. [PMID: 8697421 DOI: 10.1016/0165-4608(95)00181-6] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
The efficiency of restriction endonuclease in situ digestion (REISD) with Sau3A to analyze chimerism and residual disease (RD) has been tested before and after an allogenic bone marrow transplant (BMT) in an acute lymphoblastic leukemia (ALL) patient. The combined results obtained with REISD and FISH using the appropriate probes for detecting chromosome rearrangements have proven to be useful for the identification and quantification of both the hemopoietic chimerism achieved after BMT and the RD persistent in the patient. The sensitivity of REISD has been determined to be around 95%, i.e., similar to that obtained by FISH. REISD with Sau3A was particularly useful in the analysis of chimerism since this enzyme revealed the polymorphic status of constitutive heterochromatin in human chromosome 3 and thus allowed discrimination of cells derived from donor and recipient. The method itself seems promising since neither a donor/recipient sex mismatch nor a cytogenetic disease marker are needed for its application.
Collapse
Affiliation(s)
- J Gosálvez
- Unidad de Genética, Universidad Autónoma de Madrid, Spain
| | | | | | | | | | | | | | | |
Collapse
|
34
|
Buño I, López-Fernández C, Fernández JL, Llamas P, Díez-Martin JL, Gosálvez J. Improving chimaerism quantification in bone marrow transplant recipients by image processing and analysis after restriction endonuclease in situ digestion (IPA-REISD). Leukemia 1996; 10:1232-6. [PMID: 8684007] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
Restriction endonuclease in situ digestion (REISD) with Sau3A of human metaphase chromosomes and interphase nuclei produces a conspicuous banding pattern involving pericentromeric regions of chromosomes 9 and 3. Constitutive heterochromatin of chromosome 9 is never digested by this enzyme while that of chromosome 3 is polymorphic, giving rise to three possible karyotypes: homozygous digested (3--), homozygous undigested (3++) or heterozygous individuals (3+-). Discrimination of this polymorphism between donor and recipient cells constitutes a rapid sex-independent method to monitor quantitatively the chimaerism achieved after bone marrow transplantation. An image processing and analysis (IPA)-assisted procedure which resolves residual fluorescent regions in metaphase chromosomes or interphase nuclei after REISD has been developed. IPA-REISD has interesting advantages over the basic REISD method by allowing a rapid, objective and precise discrimination of the polymorphism in large cell samples.
Collapse
Affiliation(s)
- I Buño
- Unidad de Genetica, Departamento de Biología, Facultad de Ciencias, Universidad Autónoma de Madrid, Spain
| | | | | | | | | | | |
Collapse
|
35
|
Gosálvez J, López-Fernández C, Fernández JL, Goyanes VJ, Buño I. Digital image analysis of chromatin fibre phenotype after "in situ' digestion with restriction endonucleases. Cell Biol Int 1996; 20:213-7. [PMID: 8673070 DOI: 10.1006/cbir.1996.0026] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 02/01/2023]
Abstract
Restriction Endonucleases (REs) may recognize, cleave and remove DNA from fixed chromatin producing specific chromosome banding patterns. However, the modifications produced in the chromatin fibre are not easy to evaluate and compare. The aim of the present investigation was to visualize differences resulting in the texture of the chromatin fibre from metaphase chromosomes after each digestion using digital image analysis (DIA) facilities. To this purpose, metaphase chromosomes derived from a L-929 mouse cell line were digested with different REs (AluI, HpaII and HaeIII). Since light microscopy does not permit the observation of the chromatin fibre, DIA was performed on digitalized images of metaphase chromosomes under electron microscopy. The application of a LUT (Look Up Table) within the DIA software assigns a colour to each grey level of a digital image. The results obtained using a particular LUT, which permits the discrimination of specific chromatin fibre phenotypes resulting from each digestion, are reported and compared with those obtained under the light microscope.
Collapse
Affiliation(s)
- J Gosálvez
- Dpto. de Biología, Facultad de Ciencias, Universidad Autónoma de Madrid, Spain
| | | | | | | | | |
Collapse
|
36
|
Fernández JL, Goyanes V, López-Fernández C, Buño I, Gosálvez J. Quantification of C-ERB-B2 gene amplification in breast cancer cells using fluorescence in situ hybridization and digital image analysis. Cancer Genet Cytogenet 1996; 86:18-21. [PMID: 8616779 DOI: 10.1016/0165-4608(95)00176-x] [Citation(s) in RCA: 16] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
Fluorescence in situ hybridization (FISH) allows detection of the intercellular heterogeneity of C-ERB-B2 gene amplification in uncultured breast cancer cells. Nevertheless, because high levels of amplification result in coalescence of signals, direct microscopy quantification is restricted to cells wih low levels of amplification or with dispersed signals. A methodology of digital image analysis, using surface and grey-level FISH signals as parameters that permit a rapid, objective, and accurate estimation of gene copy number, is presented. This procedure is independent of the signal overlapping and results in a more accurate quantification and characterization of tumor cell heterogeneity.
Collapse
Affiliation(s)
- J L Fernández
- Laboratorio de Genética Molecular y Radiobiología, Hospital Teresa Herrera, Universidad Autónoma de Madrid, Spain
| | | | | | | | | |
Collapse
|
37
|
Gosálvez J, López-Fernández C, Fernández JL, Goyanes VJ, Buño I. Digital image analysis of chromatin fibre phenotype after "in situ" digestion with restriction endonucleases. Cell Biol Int 1995; 19:827-32. [PMID: 8528191 DOI: 10.1006/cbir.1995.1017] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/31/2023]
Abstract
Restriction Endonucleases (REs) may recognize, cleave and remove DNA from fixed chromatin producing specific chromosome banding patterns. However, the modifications produced in the chromatin fibre are not easy to evaluate and compare. The aim of the present investigation was to visualize differences resulting in the texture of the chromatin fibre from metaphase chromosomes after each digestion using digital image analysis (DIA) facilities. To this purpose, metaphase chromosomes derived from a L-929 mouse cell line were digested with different REs (AluI, HpaII and HaeIII). Since light microscopy does not permit the observation of the chromatin fibre, DIA was performed on digitalized images of metaphase chromosomes under electron microscopy. The application of a LUT (Look Up Table) within the DIA software assigns a colour to each grey level of a digital image. The results obtained using a particular LUT, which permits the discrimination of specific chromatin fibre phenotypes resulting from each digestion, are reported and compared with those obtained under the light microscope.
Collapse
Affiliation(s)
- J Gosálvez
- Dpto. de Biología, Edificio de Biología, Facultad de Ciencias, Universidad Autónoma de Madrid, Spain
| | | | | | | | | |
Collapse
|
38
|
Fernández JL, Campos A, Goyanes V, Buño I, Gosálvez J. Sister chromatid differentiation after in situ detection of ultraviolet-induced DNA breaks under electron microscopy. Biol Cell 1994; 82:33-7. [PMID: 7735117 DOI: 10.1016/0248-4900(94)90063-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/26/2023]
Abstract
Chinese hamster DON cells with 5-bromodeoxyuridine (BrdU)-substituted chromosomes were ultraviolet (UV)-exposed and processed for in situ detection of induced DNA breaks under electron microscopy. For this purpose, UV-induced breaks were amplified by an exonuclease III digestion to obtain single stranded DNA motifs which could hybridize with oligonucleotides of random sequences. These reannealed motifs could be used as primers which were extended by the Klenow polymerase, incorporating biotinylated-dUTP that was detected by a gold-tagged streptavidin. After processing, the chromatid whose DNA was BrdU-substituted in one strand showed a higher electron density than the chromatid substituted in both strands. In contrast, the unifilarly substituted chromatid showed about twice the labelling of DNA breaks as the bifilarly substituted one. This result could be the consequence of a greater loss of chromatin tracts in the bifilarly substituted chromatid, as implied by an X-ray microanalysis which showed that the amount of phosphorous lost by the bifilarly substituted chromatid was higher than that of the unifilarly substituted chromatid.
Collapse
Affiliation(s)
- J L Fernández
- Centro Oncológico de Galicia, Laboratorio de Dosimetría Biológica-Genética, Madrid, Spain
| | | | | | | | | |
Collapse
|